van Balkom Bas W M, Hoffert Jason D, Chou Chung-Lin, Knepper Mark A
Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1603, USA.
Am J Physiol Renal Physiol. 2004 Feb;286(2):F216-24. doi: 10.1152/ajprenal.00307.2003. Epub 2003 Oct 7.
Vasopressin regulates water and solute transport in the renal collecting duct. In addition to short-term regulation of aquaporin-2 trafficking, vasopressin also has long-term effects to regulate the abundances of aquaporins-2 and -3 and beta- and gamma-subunits of the epithelial sodium channel in collecting duct principal cells. To investigate further the direct and indirect long-term regulatory actions of vasopressin in the inner medullary collecting duct (IMCD), we used a proteomic approach [difference gel electrophoresis (DIGE) coupled with MALDI-TOF identification of differentially expressed protein spots]. DDAVP or vehicle was infused subcutaneously in Brattleboro rats for 3 days, and IMCD cells were purified from the inner medullas for proteomic analysis. Forty-three proteins were found to be regulated in response to vasopressin infusion, including 18 that were increased in abundance, 22 that were decreased, and 3 that were shifted in the gel, presumably because of posttranslational modification. Immunocytochemistry confirmed collecting duct expression of several of the proteins that were identified. Immunoblot analysis of nine of the proteins confirmed the changes seen by the DIGE method. Of these nine proteins, six were increased in response to DDAVP infusion: nitric oxide synthase-2 (NOS2), GRP78, heat shock protein-70, annexin II, glutaminase, and cathepsin D. The remaining three were decreased in response to DDAVP: aldehyde reductase I, adenylyl cyclase VI, and carbonic anhydrase II. The findings point to a role for vasopressin in the coordinate regulation of several determinants of nitric oxide levels (NOS2, arginase II, NADPH oxidase) and of proteins potentially involved in vasopressin escape (adenylyl cyclase VI and G protein-coupled receptor kinase 4).
血管加压素调节肾集合管中的水和溶质转运。除了对水通道蛋白-2转运的短期调节外,血管加压素还具有长期作用,可调节集合管主细胞中水通道蛋白-2和-3以及上皮钠通道的β和γ亚基的丰度。为了进一步研究血管加压素在内髓集合管(IMCD)中的直接和间接长期调节作用,我们采用了蛋白质组学方法[差异凝胶电泳(DIGE)结合基质辅助激光解吸电离飞行时间质谱鉴定差异表达的蛋白质斑点]。将去氨加压素(DDAVP)或赋形剂皮下注射到布拉特洛维大鼠体内3天,然后从内髓中纯化IMCD细胞进行蛋白质组学分析。发现有43种蛋白质受血管加压素输注的调节,其中18种丰度增加,22种丰度降低,3种在凝胶中发生迁移,推测是由于翻译后修饰。免疫细胞化学证实了所鉴定的几种蛋白质在集合管中的表达。对其中9种蛋白质的免疫印迹分析证实了DIGE方法所观察到的变化。在这9种蛋白质中,有6种对DDAVP输注有反应而增加:一氧化氮合酶-2(NOS2)、葡萄糖调节蛋白78(GRP78)、热休克蛋白-70、膜联蛋白II、谷氨酰胺酶和组织蛋白酶D。其余3种对DDAVP有反应而减少:醛还原酶I、腺苷酸环化酶VI和碳酸酐酶II。这些发现表明血管加压素在协调调节一氧化氮水平的几个决定因素(NOS2、精氨酸酶II、NADPH氧化酶)以及可能参与血管加压素逃逸的蛋白质(腺苷酸环化酶VI和G蛋白偶联受体激酶4)中起作用。